Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyotax and carboplatin in newly diagnosed ovarian or primary peritoneal cancer
NCT00069901Phase 2Completed
- Sponsor
- CTI BioPharma Corp.
- Start
- Feb 2003
- Primary completion
- Nov 2005
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in ovarian cancer, primary peritoneal cancer (PPC), sponsored by CTI BioPharma Corp.. Started Feb 2003; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00069901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069901.